| Nov 14 |
60 Degrees Pharmaceuticals Inc. (SXTP) Reports Q3 Loss, Misses Revenue Estimates
|
| Nov 14 |
60 Degrees Pharmaceuticals Announces Third Quarter 2024 Results
|
| Oct 3 |
60 Degrees Pharmaceuticals Inc. Announces ARAKODA® Promotional Pilot in Advance of Expanded U.S. Launch
|
| Sep 12 |
Hyliion Holdings And 2 Other Stocks Under $5 Executives Are Buying
|
| Sep 6 |
60 Degrees Pharmaceuticals, Inc. Announces Closing of $4 Million Private Placement Priced At-the-Market Under Nasdaq Rules
|
| Sep 4 |
60 Degrees Pharmaceuticals to raise $4M via private placement; shares fall
|
| Sep 4 |
60 Degrees Pharmaceuticals, Inc. Announces $4 Million Private Placement Priced At-the-Market Under Nasdaq Rules
|
| Aug 28 |
60 Degrees Pharmaceuticals, Inc. Regains Compliance with Nasdaq Listing Requirements
|
| Aug 17 |
60 Degrees Pharmaceuticals Second Quarter 2024 Earnings: Misses Expectations
|
| Aug 15 |
60 Degrees Pharmaceuticals GAAP EPS of -$4.23
|
